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CASE REPORT
FATAL SEPTICEMIA CAUSED BY Chromobacterium violaceum IN A CHILD FROM COLOMBIA
Pedro MARTINEZ & Salim MATTAR
SUMMARY
A 4-year old child living in Colombia presented with a history of fever and severe abdominal pain for four days. The patient
developed pneumonia, septic shock, multiple organ failure and died on the fifth day of hospitalization. Chromobacterium violaceum
was isolated from admission blood cultures and was resistant to ampicillin, cephalosporins, carbapenems and aminoglycosides.
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INTRODUCTION
Chromobacterium violaceum is a saprophytic bacterium found
mainly in tropical and subtropical climates. Despite its ubiquitous
distribution, human infection with this organism is rare. Since the first
human case was described in Malaysia in 1927, there have been fewer
than 150 human cases reported worldwide, mainly in Asia, the United
States, Australia, and Africa9,12. Only four cases have been reported in
South America, one in Argentina4 and three in Brazil7,10,13. Sepsis with
this organism is often found with concomitant immune deficiency
disorders, most frequently chronic granulomatous disease (CGD)5,14.
Human infection with this organism can result in severe, systemic
disease with a high fatality rate. C. violaceum infection may rapidly
progress to sepsis with multiple organ abscesses, predominantly in
lungs, liver, and spleen9,12. We report here, to the best of our knowledge,
the first Colombian case of this infection.
CASE REPORT
A 4-year old girl from rural area east Cordoba, Colombia was
admitted at the Clinica Monteria on September 1, 2006, presenting
with a history of fever, anorexia and abdominal pain for four days. The
pain was intense, continuous and localized in the upper part of the
abdomen. The patient denied nausea, vomiting or diarrhea. Physical
examination revealed palor, toxemia and the following vital signs: heart
rate 126 bpm, respiratory rate 40/minute, blood pressure 83/57 mmHg,
and temperature 37.2 oC. Chest examination revealed the presence of
wheezing. The abdomen was tense and distended, with pain in the
epigastrium and right flank upon palpation. No enlarged organs were
detected.
Laboratory investigation upon admission showed: hemoglobin 7.0
g/dL, leukocyte count 5,400/mm3, with 10% band neutrophils, 62%
segmented neutrophils, 24% lymphocytes, and 4% eosinophils, platelet
count 79,800/mm3, serum creatinine 1.4 mg/dL, blood urea 98.0 mg/
dL, and arterial gases: pH 6.92, pO
2





 15 meq/L and O
2
 saturation 100%. Blood sodium, potassium,
calcium and amylase levels were normal.
A chest radiograph revealed bilateral lobar pneumonia. Abdominal
ultrasound was normal without hypoechoic areas in the liver.
The patient was treated empirically with ceftriaxone and amikacin,
and intravenous administration of electrolytes and fluids. During the
subsequent hours the patient became comatose, with cyanosis of the
extremities and circulatory shock that did not respond to vasoactive
drugs or mechanical ventilation. The patient died on the fifth day after
admission; autopsy was not performed.
A gram-negative bacillus that formed smooth, violaceous colonies
on blood agar was isolated from two blood culture collected on
admission (Fig. 1). The bacillus was identified as C. violaceum by
the Microscan system (Dade-Behring). The isolated strain was
susceptible to chloramphenicol, tetracycline, trimethoprim-
sulfamethoxazole, and ciprofloxacin, and resistant to ampicillin,
cephalothin, cefoxitin, ceftriaxone, cefotaxime, ceftazidime,
aztreonam, imipenem, amikacin, gentamicin and tobramicin. Therapy
was changed to ciprofloxacin when identification and susceptibility
became available on the fourth hospital day. However, despite the
use of ciprofloxacin, clinical improvement was not observed and the
patient died on the fifth hospital day.
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DISCUSSION
C. violaceum, a motile and facultatively anaerobic gram-negative
bacillus, is a common inhabitant of soil and water in tropical and
subtropical areas of the world. It rarely causes invasive disease in
humans. Localized infection with regional lymphadenopathy occurs
after contamination of damaged skin exposed to soil or environmental
water. Systemic infection can occur following the aspiration or ingestion
of contaminated water2. When cultured, the organism produces large,
smooth, convex colonies with a violet-black color, although
nonpigmented strains do occur1,2.
Most cases of infection by C. violaceum have been reported from
Australia, Asia, India, Argentina, Brazil and the United States. Systemic
infection caused by C. violaceum is rare but severe and is associated
with fatality rates ≥ 60%3,8,12,13. Previous reports of C. violaceum sepsis
have noted fever, hepatic abscesses, skin lesions, facial cellulitis and
otitis1. Report of brain abscesses secondary to C. violaceum sepsis have
also been reported9,15.
 Predisposition to C. violaceum infection occurs in patients with
underlying defects in host defenses, particularly CGD5,14 and G6PD
deficiency6,11. The patient reported here had no history of previous
manifestations of abnormality in leukocyte function or
immunodeficiency disease and apparently was previously healthy. It
was not possible obtain a family history of abnormalities in leukocyte
function or immunodeficiency diseases.
The patient was in daily contact with the rural environment (river,
stagnant water) but did not present with skin lesions when admitted to
the Clinica. However, bilateral lobar pneumonia was present on
admission, suggesting inhalation as the point of entry of the infection,
with progression to septicemia. Her initial symptoms were fever and
abdominal pain, with the presence of toxemia, circulatory shock and
respiratory insufficiency. The fulminant septicemia was probably a
consequence of the lipopolysaccharide endotoxin of the organism.
The virulence of C. violaceum may have a significant role in the
development of infection, and it is attributed partly to endotoxin and
partly to inadequate host defenses9. If C. violaceum infection is
identified, therapy with trimethoprim-sulfamethoxazole and a
fluoroquinolone should be administered. Long-term treatment is needed
to fully eradicate the organism and resolve potentially fatal abscesses
in the liver or brain. Our patient died after being treated with an antibiotic
regimen that initially included ceftriaxone and amikacin, and later
ciprofloxacin, when susceptibility became available. Furthermore, the
use of carbapenems or aminoglycosides would not have been useful in
this patient due to resistance of this species to these agents.
As in other studies, the C. violaceum isolated from our patient was
resistant to ampicillin, cephalosporins and aztreonam. It was susceptible
to chloramphenicol, tetracycline, ciprofloxacin and trimethoprim-
sulfamethoxazole; the latter two antibiotics have been recommended
for the treatment of patients affected by C. violaceum. This report
documents the first case of C. violaceum in Colombia, and the possibility
of this species should be considered in patients presenting with septicemia
in Colombia, with empiric therapy broadened to include this pathogen.
RESUMEN
Septicemia mortal causada por Chromobacterium violaceum en
una paciente pediátrica de Colombia
Una niña de 4 años que vivía en Colombia presentó historia de
fiebre y dolor abdominal severo por cuatro días. La paciente desarrollo
neumonía, shock séptico, múltiple falla de órganos y muerte el quinto
día de hospitalización. Chromobacterium violaceum fue aislado de
cultivos de sangre y mostró resistencia a ampicilina, cefalosporinas,
carbapenems y aminoglicosidos.
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